PSAIiQ-Launch
Pre-launch is the highest-anxiety moment in a brand’s life, and the physician landscape is usually mapped too late to shape the advisory board properly. PSAIiQ Launch profiles your specialist landscape ahead of launch and builds the advisory structure and per-persona messaging before a single meeting happens.
Indication
A fictional specialist indication.
Executive Summary
The early-adopter physician base for this indication is concentrated among a small group of Pioneer-type specialists with active research programmes. Parallel payer engagement is essential from the outset, as access decisions in this therapy area depend on alignment across multiple ICBs and the regional medicines governance body. Advisory board composition should reflect both scientific and access perspectives from the first session.
Key Clinician
Dr Amara Osei
A UK research-intensive university · Persona Pi-T-S
Per-Persona Agency Brief — Pioneer
Headline message: “The first therapy in this class to show mechanism-level differentiation in a randomised, head-to-head setting, for the physicians who lead the evidence.”
Content requirement: Lead with mechanism differentiation and pipeline context; relegate standard efficacy slides to the appendix.
Illustrative example. Every launch profile is built individually from that brand’s own specialist landscape.